Flash Finance

Evexia Lifecare Ltd524444Corporate

Trading - Chemicals Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹1.71
MCap ₹374 Cr · P/E 200.9
Evexia Lifecare Ltd — Stock analysis & AI research Evexia Lifecare Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹31 Cr
Sales · Jun 2026
+39.8% YoY
₹1 Cr
Operating Profit · Jun 2026
-50.4% YoY
1.7%
OPM % · Jun 2026
-65.3% YoY
₹0 Cr
Net Profit · Jun 2026
-33.4% YoY
₹0.00
EPS · Jun 2026

📝 Evexia Lifecare Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Evexia Lifecare Ltd reported revenue of ₹31 crore for the quarter ended June 2026 (Q1 FY27), up 39.8% from ₹22 crore in the same quarter last year, and down 16.0% sequentially over the March 2026 quarter.

Net profit fell 33.4% year-on-year to ₹0 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.00.

Operating profit stood at ₹1 crore — an operating margin (OPM) of 1.7%, compared with 4.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Evexia Lifecare Ltd posted revenue of ₹110 crore, a growth of 17.8% over FY25, with a net profit of ₹2 crore (up 28.6% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹119 crore with a net profit of ₹2 crore.

Valuation snapshot

At the current price of ₹1.71, 524444 has a market capitalisation of ₹374 crore and a trailing P/E of about 200.9.

Within the Trading - Chemicals industry, it is the 3rd-largest of the 10 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 3.36%, foreign institutional investors (FIIs) 0.12%, domestic institutional investors (DIIs) 0.09%, public shareholders 96.41% of Evexia Lifecare Ltd.

Promoter holding slipped from 3.49% to 3.36% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹374 Cr
Current Price ?
₹1.7
P/E ?
200.88above ind
Industry P/E ?
27.10
P/B ?
0.66
P/S ?
3.15
P/FCF ?
-13.84
Enterprise Value ?
₹1,596 Cr
EV/EBITDA ?
803.58
PEG ?
5.91
Earnings Yield ?
0.1%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹119 Cr
OPM ?
1.7%
Profit after tax (TTM) ?
₹2 Cr
EPS (TTM) ?
₹0.01
ROCE ?
0.0%
ROE ?
0.3%
ROA ?
0.1%
Growth
Sales — latest qtr ?
₹31 Cr
PAT — latest qtr ?
₹0 Cr
YoY qtr sales growth ?
39.8%
YoY qtr profit growth ?
-33.4%
Sales growth (3y) ?
17%
Sales growth (5y) ?
1%
Profit growth (3y) ?
34%
Profit growth (5y) ?
4%
Financial Health
Debt ?
₹1,222 Cr
Debt to Equity ?
2.16
Interest Coverage ?
187.0
Current Ratio ?
N/A
Ownership
Promoter holding ?
3.36%
Change in promoter holding ?
-0.13%
Pledged percentage ?
N/A
Market
Return 3 months ?
4.3%
Return 6 months ?
144.3%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 251411725212722242226253731 +39.8% -16.0%
Operating Profit -00-1-03010110011 -50.4% -51.3%
Other Income 00-001000000000 — +51.4%
Interest 100-00000000000 -9.0% —
Depreciation 00000000000000 -46.5% -62.6%
Profit Before Tax -10-2-03010010011 -34.2% -37.2%
Net Profit -10-2-03010010010 -33.4% -46.2%
EPS -0.010.00-0.030.000.040.000.010.000.000.000.000.000.000.00 — —
OPM % -0.6% 1.4% -12.8% -0.1% 12.4% 1.4% 4.1% 0.8% 5.6% 4.9% 0.4% 1.0% 3.0% 1.7% -65.3% -43.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹93 Cr ₹110 Cr ₹119 Cr +17.8%
Operating Profit ₹3 Cr ₹3 Cr ₹2 Cr -12.2%
OPM % 3.09% 2.30% 1.67% -25.6%
NPM % 1.73% 1.88% 1.57% +8.7%
Other Income ₹0 Cr ₹1 Cr ₹1 Cr +243.5%
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr -15.4%
Interest ₹0 Cr ₹0 Cr ₹0 Cr -97.8%
EBIT ₹2 Cr ₹2 Cr ₹1 Cr -11.0%
PBT ₹2 Cr ₹3 Cr ₹2 Cr +41.7%
Tax — — ₹0 Cr —
Net Profit ₹2 Cr ₹2 Cr ₹2 Cr +28.6%
EPS ₹0.01 ₹0.00 ₹0.00 -100.0%
Material Cost — — ₹30 Cr —
Employee Cost — — ₹0 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Sep 2025 % Chg
Equity Capital 6671188188 +0.0%
Reserves 2459272379 +39.3%
Borrowings 7056863861,222 +216.6%
Other Liabilities 52677565 -13.3%
Total Liabilities 8488839201,853 +101.4%
Fixed Assets 11115014 -72.0%
CWIP 0001 —
Investments 704724717879 +22.6%
Other Assets 132148154959 +522.7%
Total Assets 8488839201,853 +101.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -317-2-23 -1050.0%
Cash from Investing Activity -697-17-1853 +394.4%
Cash from Financing Activity 699120-28 -240.0%
Net Cash Flow -10-02 —
Free Cash Flow -617-2-27 -1250.0%
CFO/OP -184%910%-194%-818% -321.6%

➗ Ratios (latest 4 periods)

Metric Mar 2022Mar 2023Mar 2024Mar 2025 % Chg
ROCE % 3%0%0%0% —
Debtor Days 73164282392 +39.0%
Inventory Days 711812 +50.0%
Days Payable 124186195280 +43.6%
Cash Conversion Cycle -44-1195123 +29.5%
Working Capital Days 175207343143 -58.3%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 3.49%3.36%3.49%3.36% -3.7%
FIIs 0.00%0.47%0.47%0.12% -74.5%
DIIs 0.09%0.09%0.09%0.09% +0.0%
Public 96.40%96.07%95.94%96.41% +0.5%
No. of Shareholders 1,51,5061,48,6851,46,4981,44,416 -1.4%

⚖️ Peer comparison

Industry: Trading - Chemicals · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 UNIENTER Uniphos Enterprises ₹87.30 1,214 30.0 26 20 -15.6% 77.5% -71.3% 7542.1% -100.0% -60.8%
2 VINYLINDIA Vinyl Chemicals ₹224.97 413 22.1 601 19 2.0% 3.1% 4.3% -26.1% -34.1% 48.8%
3 524444 Evexia Lifecare ₹2.91 374 — 119 2 1.7% 1.6% 17.8% 28.6% 39.8% -33.4%
4 542012 A-1 ₹343.95 288 n/m 453 9 3.6% 1.9% 3.2% 64.1% 170.5% 427.4%
5 SRD Shankar Lal ₹37.24 238 12.9 478 18 5.4% 3.9% 15.7% 18.4% 10.9% 116.8%
6 506734 Mysore Petro ₹165.80 85 10.1 56 11 -15.6% 19.1% 41.6% -64.6% 57.5% 2490.2%
7 539939 Yash Chemex ₹54.42 53 28.3 131 3 0.2% 2.0% 51.2% -12.7% -42.9% 21.1%
8 524522 Laffans Petrochemicals ₹41.02 24 — 6 -1 -45.1% -18.1% -39.5% -79.5% 261.3% -22.6%
9 539800 CHD Chemicals ₹6.49 6 — 6 -0 -4.4% -4.3% -23.8% -42.1% 27.9% 18.2%
10 543798 Patron Exim ₹8.35 4 — 24 -1 -4.8% -4.5% — — -98.0% -443.8%
❓ Frequently asked questions
What was Evexia Lifecare Ltd's revenue in Q1 FY27?
Evexia Lifecare Ltd reported revenue of ₹31 crore for the quarter ended June 2026 (Q1 FY27), up 39.8% from ₹22 crore in the same quarter last year, and down 16.0% sequentially over the March 2026 quarter.
What was Evexia Lifecare Ltd's net profit in Q1 FY27?
Net profit fell 33.4% year-on-year to ₹0 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.00.
What is 524444's market capitalisation and P/E ratio?
At the current price of ₹1.71, 524444 has a market capitalisation of ₹374 crore and a trailing P/E of about 200.9.
Who owns Evexia Lifecare Ltd? (shareholding pattern)
As of Mar 2026, promoters held 3.36%, foreign institutional investors (FIIs) 0.12%, domestic institutional investors (DIIs) 0.09%, public shareholders 96.41% of Evexia Lifecare Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI